MRO Magazine

Celanese Presents Innovations in Medical and Pharmaceutical Polymers at Drug Delivery Partnerships

January 19, 2016
By Business Wire News


Celanese Corporation (NYSE:CE), a global technology and specialty materials company, will present “Innovation in Drug Delivery: Enhancing Patient Care with EVA and Engineering Polymers” on Thursday, January 21 at the 2016 Drug Delivery Partnerships conference in Palm Beach Gardens, Fla.

“Our broad medical and pharmaceutical polymer portfolio is creating comfortable and easy-to-use drug delivery devices and implants,” said Kelsey Achenbach, strategic marketing manager for the Celanese EVA polymers business. “Improving patient care has led to recent innovations in our engineered and EVA polymer portfolios that are creating broader device and implant design options that meet changing drug delivery needs.”

During the presentation, Celanese material experts will share insights into the latest innovations in controlled release excipients and engineered polymers for complex drug delivery devices and implants, highlighting the following products:

  • VitalDose® EVA – acontrolled-release excipient ideal for use in pharmaceutical drug delivery implants that require a consistent release of active ingredients.
  • Hostaform® MT® SlideX™ POM – a tribologically-modified medical copolymer ideal for use in complex drug delivery devices, such as dry powder inhalers, pressurized metered dose inhalers, insulin pens, auto-injectors and medical pump systems.

Celanese Presentation

Topic:     Innovation in Drug Delivery:
Enhancing Patient Care with EVA and Engineering Polymers
Date: Thursday, January 21, 2016
Time(s): 12:15 – 12:35 p.m. EST
Presenters: Kelsey Achenbach, Strategic Marketing Manager – EVA Polymers
Don DeMello, Field Development Engineer – Engineered Materials

A special discount code has been created to save 15 percent on standard registration pricing. To take advantage of this promotion, visit and enter promotion code: XP2178CEL at checkout.

For more information on Celanese’s medical and pharmaceutical solutions for medical technology applications, visit

About Celanese

Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. With sales almost equally divided between North America, Europe and Asia, the company uses the full breadth of its global chemistry, technology and business expertise to create value for customers and the corporation. Celanese partners with customers to solve their most critical needs while making a positive impact on its communities and the world. Based in Dallas, Texas, Celanese employs approximately 7,500 employees worldwide and had 2014 net sales of $6.8 billion. For more information about Celanese Corporation and its product offerings, visit or our blog at

All registered trademarks are owned by Celanese International Corporation or its affiliates.

Forward-Looking Statements

This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company or its customers will realize these benefits or that these expectations will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Other risk factors include those that are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Investor Relations
Chuck Kyrish, +1 972-443-4574
Media Relations – Global
W. Travis Jacobsen, +1 972-443-3750
Media Relations Asia (Shanghai)
Helen Zhang, +86 21 3861 9279
Media Relations Europe (Germany)
Jens Kurth, +49(0)69 45009 1574